Mercer Island, WA, United States of America

Sarah Y Lee

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: **Sarah Y. Lee: Innovating Cell Therapy**

Introduction

Sarah Y. Lee, an accomplished inventor based in Mercer Island, WA, is making noteworthy contributions to the field of medical science, particularly in cell therapy. With her innovative work, she has successfully obtained a patent that addresses critical challenges in the genetic engineering of T cells, paving the way for advancements in therapeutic compositions.

Latest Patents

Sarah Y. Lee holds a significant patent titled "Process for generating therapeutic compositions of engineered cells." This invention focuses on methods for genetically engineering T cells, specifically CD4+ T cells, for use in cell therapy. The patent outlines a series of methods that include incubating the cells under stimulating conditions, introducing a recombinant polypeptide to the cells through transduction or transfection, and cultivating the cells in conditions that promote proliferation. Notably, the processes enhance efficiency and reliability, ensuring a high success rate in producing genetically engineered T cells.

Career Highlights

Currently, Sarah Y. Lee is associated with Juno Therapeutics GmbH, where she leverages her expertise in cell therapy and genetic engineering. Her commitment to innovation is evident in her works, which aim to revolutionize how therapies are developed for immune disorders and cancers. Throughout her career, she has made significant strides in advancing medical technology through her research and development efforts.

Collaborations

Sarah collaborates with notable peers, including Pascal Beauchesne and Mark L. Bonyhadi, who also contribute to the advancements in cell therapies through their respective roles. These collaborative relationships are pivotal in fostering innovation and enhancing the development of therapeutic approaches in the biotechnology field.

Conclusion

Sarah Y. Lee exemplifies the spirit of innovation in the realm of cell therapy and genetic engineering. Her pioneering patent not only contributes to the scientific community but also holds promise for improving patient outcomes in the treatment of various diseases. As she continues her work at Juno Therapeutics GmbH, the impact of her contributions is expected to resonate within the medical field for years to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…